Jubilant Pharmova net profit declines 3 percent to Rs 143 crore in Q2
Advertisement
New Delhi: Pharmaceuticals firm Jubilant Pharmova Ltd on Friday reported a 3 per cent decline in consolidated net profit from continuing operations at Rs 142.64 crore crore for the second quarter ended September 30, 2021. The company had posted a consolidated net profit of Rs 146.9 crore in the same period last fiscal, Jubilant Pharmova Ltd (JPL) said in a regulatory filing.
Consolidated total revenue from operations stood at Rs 1,657.45 crore in the second quarter as against Rs 1,591.35 crore in the year-ago period, it added.
During the quarter, the pharmaceuticals segment clocked revenue of Rs 1,543.20 crore as compared to Rs 1,516.46 crore in the comparable period a year ago.
Contract research and development services (CRDS) vertical posted revenue of Rs 116.02 crore as against Rs 80.20 crore earlier, the filing added.
JPL Chairman Shyam S Bhartia and Co-Chairman and Managing Director Hari S Bhartia in a joint statement said the topline growth during the quarter was driven by steady revenues in the pharmaceuticals segment and robust growth in the CRDS vertical.
Read also: Jubilant Pharma to remain integral to group post reorganisation: SnP
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.